- Email: [email protected]
Corrigendum to “Glucocorticoid inhibition of activation-induced cytidine deaminase expression in human B lymphocytes” [Mol. Cell. Endocrinol. 382 (2014) 881–887]
Molecular and Cellular Endocrinology 417 (2015) 211
Contents lists available at ScienceDirect
Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/locate/mce
Corrigendum
Corrigendum to “Glucocorticoid inhibition of activation-induced cytidine deaminase expression in human B lymphocytes” [Mol. Cell. Endocrinol. 382 (2014) 881e887] Ann L. Benko a, Nancy J. Olsen b, William J. Kovacs a, * a Division of Endocrinology, Diabetes, and Metabolism, The Pennsylvania State University, College of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033, United States b Division of Rheumatology, The Pennsylvania State University, College of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033, United States
The authors regret that, due a cloning artifact in the preparation of the standard for the g1/2-Cm switch circle transcript assay, the forward primer is incorrectly placed and the assay as published detects a m heavy chain transcript rather than the switch circle transcript described. The authors are re-designing the assay and will provide corrected data for parts of Figure 2 and Figure 3 when the experiments are completed. The error does not affect any other findings or the conclusions of the manuscript as published. Investigators should not use the g1/2-Cm switch circle transcript assay as currently described in Methods. The authors will provide amended primer/probe sequences when the revised assay is validated. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.mce.2013.11.001. * Corresponding author. The Pennsylvania State University, College of Medicine, Division of Endocrinology, Diabetes, and Metabolism, 500 University Drive, Hershey, PA 17033-0850, United States. E-mail address: [email protected] (W.J. Kovacs). http://dx.doi.org/10.1016/j.mce.2015.10.019 0303-7207/© 2015 Elsevier Ireland Ltd. All rights reserved.
Contents lists available at ScienceDirect
Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/locate/mce
Corrigendum
Corrigendum to “Glucocorticoid inhibition of activation-induced cytidine deaminase expression in human B lymphocytes” [Mol. Cell. Endocrinol. 382 (2014) 881e887] Ann L. Benko a, Nancy J. Olsen b, William J. Kovacs a, * a Division of Endocrinology, Diabetes, and Metabolism, The Pennsylvania State University, College of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033, United States b Division of Rheumatology, The Pennsylvania State University, College of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033, United States
The authors regret that, due a cloning artifact in the preparation of the standard for the g1/2-Cm switch circle transcript assay, the forward primer is incorrectly placed and the assay as published detects a m heavy chain transcript rather than the switch circle transcript described. The authors are re-designing the assay and will provide corrected data for parts of Figure 2 and Figure 3 when the experiments are completed. The error does not affect any other findings or the conclusions of the manuscript as published. Investigators should not use the g1/2-Cm switch circle transcript assay as currently described in Methods. The authors will provide amended primer/probe sequences when the revised assay is validated. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.mce.2013.11.001. * Corresponding author. The Pennsylvania State University, College of Medicine, Division of Endocrinology, Diabetes, and Metabolism, 500 University Drive, Hershey, PA 17033-0850, United States. E-mail address: [email protected] (W.J. Kovacs). http://dx.doi.org/10.1016/j.mce.2015.10.019 0303-7207/© 2015 Elsevier Ireland Ltd. All rights reserved.